compounsing semaglutide ending fda compounding news october 2025 Drug compounders sue over declaration Wegovy shortage FDA cracks down on weight-loss compound semaglutide shortage Compounding pharmacies

The Independent Pharmacy Survival Question One consequence of PBM consolidation that does not fit neatly into the narrative about large-scale reform is the devastation of independent retail pharmacy

This kind of improved access helps the market grow by bringing the drug to a wider group of patients

The primary goal of treatment should extend beyond weight loss to encompass the preservation of lean mass, improvement in metabolic health, and long-term prevention of obesity-related complications [7]

Because compounded medications are not subject to the same clinical trials as FDA-approved drugs, there is limited research directly comparing the efficacy of compounded semaglutide against Wegovy

In clinical trials, its ability to reduce weight is anywhere from 22 to 29 percent, which literally exceeds gastric sleeve surgery